Concepedia
Statistics
Publications
9
Citations
228
H-Index
Active since
2022
Affiliations
Harvard University(Current)
Mount Auburn Hospital
National Taiwan University Hospital
Taipei Tzu Chi Hospital
Chung Shan Medical University
Cho‐Hung Chiang is an author at Harvard University specializing in pharmacology, medicine, and immune checkpoint inhibitors.
Publications per year
2022–2025
Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer
Cho‐Han Chiang, Cho‐Hung Chiang, Cho‐Hung Chiang et al. · Heart · 2022 · 61 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +13
Efficacy of cationic amphiphilic antihistamines on outcomes of patients treated with immune checkpoint inhibitors
Cho‐Han Chiang, Cho‐Han Chiang, Cho‐Hung Chiang et al. · European Journal of Cancer · 2022 · 44 citations
Life Sciences, Immunology, Pharmacology +14
The incidence and risk of cardiovascular events associated with immune checkpoint inhibitors in Asian populations
Cho‐Han Chiang, Cho‐Hung Chiang, Kevin Sheng‐Kai et al. · Japanese Journal of Clinical Oncology · 2022 · 32 citations · Full text
Medicine, Cardiology, Oncology +12
The impact of sodium‐glucose cotransporter‐2 inhibitors on outcome of patients with diabetes mellitus and colorectal cancer
Cho‐Han Chiang, Cho‐Han Chiang, Cho‐Hung Chiang et al. · Journal of Gastroenterology and Hepatology · 2024 · 25 citations · Full text
Medicine, Oncology, Pharmacology +13
Glucagon-like peptide 1 receptor agonists and venous thromboembolism in type 2 diabetes: a target trial emulation
Cho‐Han Chiang, Junmin Song, Yu‐Cheng Chang et al. · Blood Advances · 2025 · 17 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +17
1–5 of 9